Pay to Marwadi

Company Profile

NEOGEN CHEMICALS LTD.

NSE : NEOGENBSE : 542665ISIN CODE : INE136S01016Industry : ChemicalsHouse : Private
BSE1538.70-31.8 (-2.02 % )
PREV CLOSE (Rs.) 1570.50
OPEN PRICE (Rs.) 1570.50
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 10037
TODAY'S LOW / HIGH (Rs.)1521.05 1584.85
52 WK LOW / HIGH (Rs.)1148.8 1851.05
NSE1539.60 -30.85 (-1.96 % )
PREV CLOSE(Rs.) 1570.45
OPEN PRICE (Rs.) 1581.35
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 1539.60 (79 )
VOLUME 43123
TODAY'S LOW / HIGH(Rs.) 1521.15 1587.80
52 WK LOW / HIGH (Rs.)1176 1859.3

Company Profile

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 0.13
TTM EPS (Rs.) 16.70
P/E Ratio 92.13
Book Value (Rs.) 290.13
Face Value (Rs.) 10
MCap (Rs. in Mn) 40593.48
Price/Earning (TTM) 63.48
Price/Sales (TTM) 5.83
Price/Book (MRQ) 5.30
PAT Margin (%) 7.29
ROCE (%) 13.26
Incorporation Year : 1989

Management Info :

Haridas Thakarshi Kanani - Chairman Harin Haridas Kanani - Managing Director

Registered Office :

Address : Office No., 1002, 10th Floor,Dev Corpora Bldg, Opp. Cadbury Co,Pokhran Road No. 2, Khopat,
Thane,
Maharashtra-400601

Phone : 022 2549 7300

Website : www.neogenchem.com

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS More
02May05-02-2024$Neogen Chemicals informs about earnings presentation Neogen Chemicals informs abo

Neogen Chemicals has informed that it enclosed the Earnings Presentation on the audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2024. The audited Financial Results for the quarter and year ended March 31, 2024, and the Earnings Presentation are also being uploaded on the Company’s website at https://neogenchem.com/financial-performance/.

The above information is a part of company’s filings submitted to BSE.
Neogen Chemicals has informed that it enclosed the Earnings Pre..
02May05-02-2024$Neogen Chemicals informs about press release Neogen Chemicals informs abo

Neogen Chemicals has informed that it enclosed the Press Release on the audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2024. The Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2024 and the Press Release are also being uploaded on the Company’s website at https://neogenchem.com/financial-performance/.

The above information is a part of company’s filings submitted to BSE.
Neogen Chemicals has informed that it enclosed the Press Releas..
02May05-02-2024$Allotment of Debentures Allotment of Debentures
Inter alia, approved:- 1. Recommended a final dividend of Rs. 2.00 per Equity Share for the Financial Year 2023-24, subject to approval of shareholders at the ensuing Annual General Meeting of the Company 2. Pledge of Equity shares of WOS- NIL held by Neogen Chemicals Limited against the credit facilities to be availed by Neogen Ionics Limited. 3. In principle approval for subscription of upto 50,00,00,000 Compulsorily Convertible Debentures (?CCDs?) with coupon rate of 0.01% p.a. of a face value of Rs. 10 each amounting to Rs. 500,00,00,000 (Rupees Five Hundred Crores only) to be issued, offered and allotted on a rights basis by its WOS-NIL. 4. Subscription of upto 49,00,000 equity shares of a face value Rs. 10 each amounting to Rs. 4,90,00,000 (Rupees Four Crores Ninety Lakhs only) to be issued, offered and allotted on rights basis of its WOS- NIL. 5. The draft Scheme of Amalgamation of Buli Chemicals India Private Limited - wholly owned subsidiary ("Transferor Company?) with Neogen Chemical Limited- the holding company (?Transferee Company?) and their respective shareholders ("Scheme"), based on the recommendation of the Audit Committee, under section 230 to 232 and other applicable provisions of the Companies Act, 2013 and rules framed thereunder. The Scheme inter alia provides for the amalgamation of the Transferor Company with the Transferee Company. The Transferor Company is the wholly owned subsidiary of the Transferee Company. The Scheme is subject to necessary statutory and regulatory approvals under the applicable laws, including approval of the jurisdictional Hon?ble National Company Law Tribunal.
Inter alia, approved:- 1. Recommended a final dividend of Rs...
02May05-02-2024$Amalgamation Amalgamation
Inter alia, approved:- 1. Recommended a final dividend of Rs. 2.00 per Equity Share for the Financial Year 2023-24, subject to approval of shareholders at the ensuing Annual General Meeting of the Company 2. Pledge of Equity shares of WOS- NIL held by Neogen Chemicals Limited against the credit facilities to be availed by Neogen Ionics Limited. 3. In principle approval for subscription of upto 50,00,00,000 Compulsorily Convertible Debentures (?CCDs?) with coupon rate of 0.01% p.a. of a face value of Rs. 10 each amounting to Rs. 500,00,00,000 (Rupees Five Hundred Crores only) to be issued, offered and allotted on a rights basis by its WOS-NIL. 4. Subscription of upto 49,00,000 equity shares of a face value Rs. 10 each amounting to Rs. 4,90,00,000 (Rupees Four Crores Ninety Lakhs only) to be issued, offered and allotted on rights basis of its WOS- NIL. 5. The draft Scheme of Amalgamation of Buli Chemicals India Private Limited - wholly owned subsidiary ("Transferor Company?) with Neogen Chemical Limited- the holding company (?Transferee Company?) and their respective shareholders ("Scheme"), based on the recommendation of the Audit Committee, under section 230 to 232 and other applicable provisions of the Companies Act, 2013 and rules framed thereunder. The Scheme inter alia provides for the amalgamation of the Transferor Company with the Transferee Company. The Transferor Company is the wholly owned subsidiary of the Transferee Company. The Scheme is subject to necessary statutory and regulatory approvals under the applicable laws, including approval of the jurisdictional Hon?ble National Company Law Tribunal.
Inter alia, approved:- 1. Recommended a final dividend of Rs...
12Mar03-12-2024$Neogen Chemicals submits analyst meet intimation Neogen Chemicals submits ana
Pursuant to Regulation 30 of the Listing Regulations, Neogen Chemicals has informed that the management of Neogen Chemicals will be participating in the Analysts/Investors Group meeting on May 29, 2024. The discussion will be within the purview of Neogen Chemicals’ business overview, financial performance and outlook. Further, this intimation is also uploaded on the company’s website at https://neogenchem.com/investor-meet-presentation/

The above information is a part of company’s filings submitted to BSE. 

Pursuant to Regulation 30 of the Listing Regulations, Neogen Ch..
Financials More
Rs. in Millions
QTR Mar 24 ANNUAL 24
Net Profit177440.6
Gross Profit 232.3 636.4
Operating Profit 377.11243.6
Net Sales 1906.36963.6
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Keltech Energies (BSE)
 4704.85 (5.00%)
M.Cap ( in Cr)
470.49
Atul (BSE)
 6140.15 (2.37%)
M.Cap ( in Cr)
18077.68
Solar Industries (BSE)
 8999.85 (1.52%)
M.Cap ( in Cr)
81439.69
Fischer Chemic (BSE)
 527.25 (5.00%)
M.Cap ( in Cr)
2820.79
Tatva Chintan Pharma (BSE)
 1245.55 (1.51%)
M.Cap ( in Cr)
2913.60
Shareholding Pattern More
PROMOTERS 56.89 %
MUTUAL FUNDS/UTI 20.32 %
NON-INSTITUTION 16.41 %
FI/BANKS/INSURANCE 1.02 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS More
F & O Quotes